Form 8-K - Current report:
SEC Accession No. 0001493152-25-020920
Filing Date
2025-11-06
Accepted
2025-11-05 18:00:28
Documents
15
Period of Report
2025-11-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 44699
2 EX-10.1 ex10-1.htm EX-10.1 53115
3 GRAPHIC form8-k_001.jpg GRAPHIC 5921
  Complete submission text file 0001493152-25-020920.txt   336970

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bgms-20251105.xsd EX-101.SCH 3749
5 XBRL DEFINITION FILE bgms-20251105_def.xml EX-101.DEF 26585
6 XBRL LABEL FILE bgms-20251105_lab.xml EX-101.LAB 36613
7 XBRL PRESENTATION FILE bgms-20251105_pre.xml EX-101.PRE 25209
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5747
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Bio Green Med Solution, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 251455378
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)